Showing results (1-10 of 628) with videos related to
Sort By:
Pageof 63
International Journal of Oncology|May 14, 2011
Proteases associated with gynecological tumorsC Ruppert, S Ehrenforth, B Tutschek, et al.Cancer Detection and Prevention|January 1, 1997
Protease levels in breast, ovary, and other gynecological tumor tissues: prognostic importance in breast cancerC Ruppert, S Ehrenforth, I Scharrer, et al.International Journal of Oncology|May 17, 2011
Biochemical and immunohistochemical detection of the epidermal growth-factor receptor (EGF-R) in breast-tumor specimensM Beckmann, B Tutschek, K Kruger, et al.Seminars in Thrombosis and Hemostasis|May 18, 1999
Liver damage induced by coumarin anticoagulantsS Ehrenforth, J F Schenk, I ScharrerOncology Reports|May 20, 2011
pS2 protein detected by immunohistochemistry in archival primary breast cancerB Tutschek, D Niederacher, M Caminada, et al.Deutsche Medizinische Wochenschrift (1946)|July 22, 1999
[Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population]S Ehrenforth, S Klinke, M von Depka Prondzinski, et al.Vox Sanguinis|January 1, 1994
Screening of F.VIII:C antibodies by an enzyme-linked immunosorbent assayW Mondorf, S Ehrenforth, Z Vigh, et al.Thrombosis and Haemostasis|January 5, 2002
Prevalence of a 23bp insertion in exon 3 of the endothelial cell protein C receptor gene in venous thrombophiliaM von Depka, A Czwalinna, R Eisert, et al.European Journal of Pediatrics|January 29, 2000
Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Childhood Thrombophilia Study GroupS Ehrenforth, R Junker, H G Koch, et al.Lancet (London, England)|March 7, 1992
Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsS Ehrenforth, W Kreuz, I Scharrer, et al.Pageof 63